Quiñones-Galvan A - Search Results

1

Metabolic effects of combined antihypertensive treatment in patients with essential hypertension.

Quiñones-Galvan A, Pucciarelli A, Ciociaro D, Masoni A, Franzoni F, Natali A, Ferrannini E. Quiñones-Galvan A, et al. J Cardiovasc Pharmacol. 2002 Dec;40(6):916-21. doi: 10.1097/00005344-200212000-00013. J Cardiovasc Pharmacol. 2002. PMID: 12451325 Clinical Trial.

2

Effective blood pressure treatment improves LDL-cholesterol susceptibility to oxidation in patients with essential hypertension.

Quiñones-Galvan A, Pucciarelli A, Fratta-Pasini A, Garbin U, Franzoni F, Galetta F, Natali A, Cominacini L, Ferrannini E. Quiñones-Galvan A, et al. J Intern Med. 2001 Oct;250(4):322-6. doi: 10.1046/j.1365-2796.2001.00844.x. J Intern Med. 2001. PMID: 11576319 Free article. Clinical Trial.

3

Insulin resistance in microalbuminuric hypertension. Sites and mechanisms.

Bianchi S, Bigazzi R, Quiñones Galvan A, Muscelli E, Baldari G, Pecori N, Ciociaro D, Ferrannini E, Natali A. Bianchi S, et al. Hypertension. 1995 Nov;26(5):789-95. doi: 10.1161/01.hyp.26.5.789. Hypertension. 1995. PMID: 7591019

4

Relationship between insulin release, antinatriuresis and hypokalaemia after glucose ingestion in normal and hypertensive man.

Natali A, Quiñones Galvan A, Santoro D, Pecori N, Taddei S, Salvetti A, Ferrannini E. Natali A, et al. Clin Sci (Lond). 1993 Sep;85(3):327-35. doi: 10.1042/cs0850327. Clin Sci (Lond). 1993. PMID: 8403806 Clinical Trial.

5

Renovascular hypertension and insulin sensitivity.

Natali A, Quiñones Galvan A, Arzilli F, Taddei S, Pecori N, Frascerra S, Salvetti A, Ferrannini E. Natali A, et al. Eur J Clin Invest. 1996 Jul;26(7):556-63. doi: 10.1046/j.1365-2362.1996.1740521.x. Eur J Clin Invest. 1996. PMID: 8864417

6

Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension.

Natali A, Taddei S, Quiñones Galvan A, Camastra S, Baldi S, Frascerra S, Virdis A, Sudano I, Salvetti A, Ferrannini E. Natali A, et al. Circulation. 1997 Aug 5;96(3):849-55. doi: 10.1161/01.cir.96.3.849. Circulation. 1997. PMID: 9264492

7

Renal effects of insulin in man.

Quiñones-Galvan A, Ferrannini E. Quiñones-Galvan A, et al. J Nephrol. 1997 Jul-Aug;10(4):188-91. J Nephrol. 1997. PMID: 9377725 Review.

8

Vasodilation with sodium nitroprusside does not improve insulin action in essential hypertension.

Natali A, Quiñones Galvan A, Pecori N, Sanna G, Toschi E, Ferrannini E. Natali A, et al. Hypertension. 1998 Feb;31(2):632-6. doi: 10.1161/01.hyp.31.2.632. Hypertension. 1998. PMID: 9461233 Clinical Trial.

9

Metabolic effects of glucose-insulin infusions: myocardium and whole body.

Quiñones-Galvan A, Ferrannini E. Quiñones-Galvan A, et al. Curr Opin Clin Nutr Metab Care. 2001 Mar;4(2):157-63. doi: 10.1097/00075197-200103000-00013. Curr Opin Clin Nutr Metab Care. 2001. PMID: 11224662 Review.

10

A comparative study of the in vitro antioxidant activity of statins.

Franzoni F, Quiñones-Galvan A, Regoli F, Ferrannini E, Galetta F. Franzoni F, et al. Among authors: quinones galvan a. Int J Cardiol. 2003 Aug;90(2-3):317-21. doi: 10.1016/s0167-5273(02)00577-6. Int J Cardiol. 2003. PMID: 12957768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page